LABORATORY RESEARCH Gene Induction and Repression During Terminal Erythropoiesis Are Mediated by Distinct Epigenetic Changes Here scientists use global mRNA sequencing and chromatin immunoprecipitation coupled to high-throughput sequencing to investigate the changes that occur in mRNA levels, RNA Polymerase II occupancy and multiple post-translational histone modifications when erythroid progenitors differentiate into late erythroblasts. [Blood] A Blood Flow-Dependent klf2a-Nitric Oxide Signaling Cascade Is Required for Stabilization of Hematopoietic Stem Cell Programming in Zebrafish Embryos Here, investigators take advantage of zebrafish embryos with circulation defects that retain relatively normal early development to illustrate the combinatorial roles of genetic and hemodynamic forces in hematopoietic stem cell development. [Blood] Ten-Eleven-Translocation 2 (TET2) Negatively Regulates Homeostasis and Differentiation of Hematopoietic Stem Cells in Mice By analyzing mice with targeted disruption of the Tet2 catalytic domain, scientists show here that Tet2 is a critical regulator of self-renewal and differentiation of hematopoietic stem cells. [Proc Natl Acad Sci U S A] TGFβ Inhibition Enhances the Generation of Hematopoietic Progenitors from Human Embryonic Stem Cell-Derived Hemogenic Endothelial Cells Using a Stepwise Strategy Here, on the basis of the emergence of CD43+ hematopoietic cells from hemogenic endothelial (HE) cells, researchers demonstrated that VEGF was essential and sufficient, and that bFGF was synergistic with VEGF to specify the HE cells and the subsequent transition into CD43+ hematopoietic cells. [Cell Res] Absence of IL-12Rβ2 in CD33+CD38+ Pediatric Acute Myeloid Leukemia Cells Favors Progression in NOD/SCID/IL2RγC-Deficient Mice Scientists investigated whether interleukin (IL)-12 may target acute myeloid leukemia blasts (CD45+CD33+) and populations known to contain leukemia initiating cells (that is, CD34+CD38−, CD33+CD38+ and CD44+CD38− cells). [Leukemia] Stem Cell Factor Consistently Improves Thymopoiesis After Experimental Transplantation of Murine or Human Hematopoietic Stem Cells in Immunodeficient Mice Investigators evaluated whether stem cell factor administration would improve recovery of thymopoiesis following hematopoietic stem cell transplantation (HSCT) in immunodeficient mice receiving: 1) bone marrow transplantation of congenic mice; or 2) human fetal liver HSCT in the human immune system mouse model. [J Immunol] Enhancing the Anti-Lymphoma Potential of 3,4-Methylenedioxymethamphetamine (‘Ecstasy’) through Iterative Chemical Redesign: Mechanisms and Pathways to Cell Death From an initial analysis of 3,4-methylenedioxymethamphetamine (MDMA) analogs synthesized with a modified α-substituent, it was found that incorporating a phenyl group increased potency against sensitive, Bcl-2-deplete, Burkitt’s lymphoma cells 10-fold relative to MDMA. [Invest New Drugs] CLINICAL RESEARCH Access to Allogeneic Hematopoietic SCT for Patients with MDS or Relapsed AML Treated According to Protocols of the Dutch Childhood Oncology Group To investigate whether all patients in need of an allogeneic hematopoietic SCT are offered one, scientists retrospectively investigated the policy for all children diagnosed with myelodysplastic syndrome (n=90) or relapsed AML (n=75) between 1998 and 2008. [Bone Marrow Transplant] Functional Genetic Variations of Cyclooxygenase-2 and Susceptibility to Acute Myeloid Leukemia in a Chinese Population In this case-control study, the genotypes of potential functional SNPs in cyclooxygenase-2 (COX-2) gene were determined with PCR-RFLP method in 446 patients and 725 controls. [Eur J Haematol] |